-
Honor Your Body
Coming to terms with feelings and emotions about weight gain and weight loss is often part of a cancer patient's experience.
by Sue Rochman
-
In the Moment- Winter 2015/2016
Jared Levinthall, Carol Dellinger, Anne Ha.
-
Survivor Profile
Changing CourseDuring her treatment for breast cancer, biomedical engineer Jessica Winter challenged her laboratory to bring its discoveries to patients more quickly.
by Chris Palmer
-
In the Moment- Fall 2015
Chris Hixon, Lesley K. Glenn, Kristina Giard-Bradford.
-
First Person
To Test or Not to TestTwenty-two years after the first of two breast cancer diagnoses, a survivor decides to undergo genetic testing.
by Cynthia Ryan
-
Breaking the Blood-Brain Barrier
Advances in treating brain metastases and reducing their side effects are bringing new hope to cancer patients.
by Sue Rochman
-
Survivor Profile
Stop the SilenceCancer survivor Cherry Sloan-Medrano works to encourage a conversation about cancer among Asians in the U.S.
by Jenny Song
-
Yesterday & Today
Taking Her PlaceGeraldine Ferraro, the first woman nominated for vice president on a major-party ticket, used her political prowess to advocate for women's equality. In 1998, she was diagnosed with multiple myeloma.
by Sharlene George
-
Colorectal Cancer: A Troubling Trend
More people are being diagnosed with colorectal cancer before 50, the recommended age to start screening.
by Charlotte Huff
-
The Work-Cancer Balance
Some patients want to work through illness and others need to, but juggling work responsibilities and treatment regimens can be a challenge.
by Leigh Labrie
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff